| 摘要 |
The use of acyclovir or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment (including prophylaxis) of post-herpetic neuralgia (PHN). |
